Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Glycemic Control in Acute Leukemia
NCT00943709Phase 3Withdrawn
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- May 2009
- Primary completion
- Mar 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine, insulin glulisine in hyperglycemia, sponsored by University of Medicine and Dentistry of New Jersey. Planned start May 2009; status: withdrawn.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT00943709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943709.